Diametric Capital’s Collegium Pharmaceutical COLL Stock Holding History

Diametric Capital’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,031	Closed	-$210K	–	331
2025 Q1	$210K	Buy	+7,031	New	+$215K	0.25%	134
2023 Q1	–	Sell	-13,370	Closed	-$310K	–	370
2022 Q4	$310K	Sell	13,370 -16,126	-55%	-$325K	0.15%	198
2022 Q3	$473K	Buy	+29,496	New	+$520K	0.24%	142
2022 Q1	–	Sell	-18,064	Closed	-$537K	–	271
2021 Q4	$537K	Buy	+18,064	New	+$352K	0.41%	55
2021 Q2	–	Sell	-13,519	Closed	-$320K	–	147
2021 Q1	$320K	Sell	13,519 -8,846	-40%	-$210K	0.24%	95
2020 Q4	$448K	Buy	+22,365	New	+$437K	0.36%	85
2020 Q3	–	Sell	-51,634	Closed	-$904K	–	136
2020 Q2	$904K	Sell	51,634 -4,265	-8%	-$83.5K	0.69%	61
2020 Q1	$913K	Buy	+55,899	New	+$1.15M	1.11%	35

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diametric Capital's COLL Position: Q2 2025 in Review

Diametric Capital sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 7,031 shares — an estimated $210K sold.

Diametric Capital first reported a position in COLL in Q1 2020 and held it in 8 quarters. The position peaked at $913K in Q1 2020. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

Diametric Capital reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Diametric Capital sold 7,031 Collegium Pharmaceutical shares in Q2 2025, an estimated $210K.
Diametric Capital first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 8 quarters.
Diametric Capital's Collegium Pharmaceutical position peaked at $913K in Q1 2020.
223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Diametric Capital's 13F filing for Q2 2025, filed 13 Aug 2025.